MedPath

A clinical trial to study the effects of two different doses of injection hyperbaric ropivacaine in spinal anaesthesia for lower abdominal and leg surgeries.

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2022/10/046357
Lead Sponsor
Dr Prashant Atmaram Lomate
Brief Summary

the proposed RCT comparing the efficacy of two different volumes of 0.75% hyperbaric ropivacaine for spinal anaesthesia in infraumbilical surgeries is innovative. the primary and secondary outcomes of the study are expected to add greatly to the understanding of the ideal drug volume of inj ropivacaine. the central hypothesis of the proposed research is that the quality of spinal anaesthesia in terms of duration oof analgesia;and onset and offset times of sensory-motor blockade will be better with 2.4cc than 2cc of 0.75% hyperbaric ropivacaine during infraumbilical surgeries under spinal anaesthesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

1.ASA grade I or grade II patients 2.Either sex 3.Age- 18 to 60 years 4.Scheduled for elective infraumbilical surgeries under spinal anaesthesia.

Exclusion Criteria
  • 1.Patient refusal to participate in the study.
  • 2.Known hypersensitivity to local anaesthetics 3.Bleeding disorders 4.Anatomic abnormality of spine 5.Severe systemic diseases 6.Pregnant patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
duration of analgesia after 2cc and 2.4cc volumes of 0.75% hyperbaric ropivacaine when given for spinal anaesthesia during infraumbilical surgeries.duration of analgesia- assesses for 24 hours.
Secondary Outcome Measures
NameTimeMethod
1.onset times of sensory and motor block.2.duration of sensory and motor block

Trial Locations

Locations (1)

Bharati Vidyapeeth (deemed to be university) Medical College and Hospital, Sangli.

🇮🇳

Sangli, MAHARASHTRA, India

Bharati Vidyapeeth (deemed to be university) Medical College and Hospital, Sangli.
🇮🇳Sangli, MAHARASHTRA, India
Dr Prashant Atmaram Lomate
Principal investigator
09823295177
drprashantlomate@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.